Due to persistent delays in deliveries of vaccines to the EU, on March 11, 2021 the European Commission adopted the new Implementing Regulation (EU) 2021/442, renewing, with amendments, through the end of June, the transparency and authorization mechanism for COVID-19 vaccine exports.
The New Insolvency Code introduced several innovations to the traditional system of management and detection of company business crisis. In this respect, the experience of the 231 compliance programs may be considered a key benchmark.
On May 19, 2020, the Italian government adopted decree law no. 34, setting out urgent measures with immediate effect to support health, work, and the economy, as well as social policies related to the epidemiological emergency (the “Decree”).
In response to the COVID-19 emergency, the Commission took measures to protect the availability of supplies of personal protective equipment, namely by adopting two Implementing Regulations, which required exports of such equipment outside of the European Union to be subject to an export authorization from Member States.
The coronavirus emergency has forced companies to face an array of unprecedented challenges, among them the requirements that ensure compliance with Legislative Decree No. 231/2001, which introduced corporate criminal liability in Italian legislation.